Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 9/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LSS | P48449 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7143170 | 0.89 | MGLL (0.43) | MGLLMAPTPOLBMEN1KMT2A | |
| SCHEMBL6448121 | 0.86 | LSS (0.46) | MGLLMAPTPOLBMEN1KMT2A | |
| SCHEMBL7142436 | 0.85 | LSS (0.46) | MGLLLSS | |
| SCHEMBL7139780 | 0.83 | MGLL (0.46) | MGLLMAPTPOLBMEN1KMT2A | |
| SCHEMBL6448159 | 0.79 | LSS (0.52) | MGLLMAPTPOLBMEN1KMT2A | |
| SCHEMBL5038776 | 0.78 | LSS (0.45) | MGLLMAPTPOLBMEN1KMT2A | |
| SCHEMBL5040564 | 0.78 | HRH3 (0.52) | MGLLMAPTPOLBMEN1KMT2A | |
| SCHEMBL7143062 | 0.78 | LSS (0.46) | MGLLMAPTPOLBMEN1KMT2A | |
| SCHEMBL5043392 | 0.78 | HRH3 (0.51) | MGLLMAPTMEN1KMT2AHSD11B1 | |
| SCHEMBL5039302 | 0.78 | HRH3 (0.48) | MGLLMAPTPOLBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1317432-A1 | PIPERIDINE DERIVATIVES FOR USE AS 2,3-OXIDOSQUALENE-LANOSTEROL CYCLASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2003-06-11 | — | — | EP | disclosed |
| WO-2002020483-A1 | PIPERIDINE DERIVATIVES FOR USE 2,3-OXIDOSQUALENE-LANOSTEROL CYCLASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-03-14 | — | — | WO | disclosed |